OVERALL SURVIVAL ANALYSIS ADJUSTING FOR TREATMENT EFFECT AFTER CROSSOVER IN A PHASE 3 STUDY EVALUATING IDELALISIB IN COMBINATION WITH RITUXIMAB IN RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
HAEMATOLOGICA（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要